 FLORHAM PARK, N.J., Jan. 05, 2021 GLOBE NEWSWIRE -- PDS Biotechnology Corporation Nasdaq: PDSB, a clinical-stage immunotherapy company developing novel cancer therapies and infectious disease vaccines based on the Companys proprietary Versamune T-cell activating technology, today announced that Chief Executive Officer Dr. Frank Bedu-Addo will be presenting at H.C. Wainwrights BioConnect virtual conference. PDS Biotechs presentation will be available on-demand beginning January 11, 2021 at 6:00 AM ET and can be accessed online here. 